Children’s Panadol® 1-5 Years Suspension temporarily out of stock

The makers of Children’s Panadol®, GSK, today confirmed that their Children’s Panadol® 1-5 years suspension range would be out of stock for a limited period, due to a competitor patent challenge.

The makers of Children’s Panadol®, GSK, today confirmed that their Children’s Panadol® 1-5 years suspension range would be out of stock for a limited period, due to a competitor patent challenge.

While Children’s Panadol® 1-5 years suspension is unavailable, parents should seek advice from their doctor or local pharmacist about other Children’s Panadol® products that may be a suitable alternative for their child.

Vincent Cotard, GSK General Manager Consumer Healthcare ANZ reiterated that there are no safety, efficacy or formulation issues with Children’s Panadol® 1-5 years suspension.

“We are working hard to ensure that Children’s Panadol® 1-5 years suspension is available again as soon as possible,” Vincent Cotard said.

“Only the new Children’s Panadol® 1-5 years suspension is affected. Children’s Panadol® Baby Drops, Children’s Panadol® 5-12 years Elixir and the new Children’s Panadol® 5-12 years suspensions are not impacted and remain available from pharmacies.”

While the Children’s Panadol® 1-5 years suspension range is unavailable in pharmacies, consumers are advised to speak to their pharmacist about using other Children’s Panadol® products that may be a suitable alternative.

The products in the Children’s Panadol® range contain different concentrations of the active ingredient, paracetamol. The dosage instructions for each product in the range are different due to different concentrations of paracetamol in each product. The dosage guidelines provided with all Children’s Panadol products should be followed carefully.

Parents can also access the dosage calculator at www.ChildrensPanadol.com.au. The dosage calculator and guidelines enable parents to determine the right amount for their child based on their weight and age.

Children’s Panadol® has been trusted by generations to provide fast, effective and gentle pain relief for children from as young as one month. Panadol® has been rated Australia’s most trusted pain reliever brand, according to research released yesterday by Reader’s Digest1.

Children’s Panadol® can start to relieve fever in just 15 minutes2, and provides effective relief from fever and pain associated with teething, immunisation, earache, headache, and cold and flu symptoms.

For more information about Children’s Panadol® and the patent challenge, please visit www.gsk.com.au

Whenever using Children’s Panadol® ALWAYS READ THE LABEL. Use only as directed. For the temporary relief of pain and fever. Incorrect use could be harmful. Consult your healthcare professional if symptoms persist.

CHILDREN’S PANADOL® is a registered trademark of the GlaxoSmithKline group of companies

GlaxoSmithKline (GSK) are the makers of Panadol®. We are a global research-based pharmaceutical and healthcare company with a proud history in Australia dating back to 1886. Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer.

-ENDS-

This press release has been issued on behalf of GSK by VIVA! Communications.
For more information, please contact Melissa Chlad, VIVA! Communications on 0488 440 274.

1Readers Digest 2013, Australia's Most Trusted Brands of 2013
2Refers only to non-prescription medicines and is based on the liquid paracetamol formulation given at a dosage of 15mg / kg